Tower Research Capital (TRC)’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2K | Buy |
12,571
+1,862
| +17% | +$2.7K | ﹤0.01% | 3737 |
|
|
2025
Q1 | $14.8K | Buy |
10,709
+4,549
| +74% | +$6.28K | ﹤0.01% | 3263 |
|
|
2024
Q4 | $18.7K | Sell |
6,160
-1,889
| -23% | -$5.74K | ﹤0.01% | 3240 |
|
|
2024
Q3 | $40.1K | Buy |
8,049
+3,825
| +91% | +$19K | ﹤0.01% | 2845 |
|
|
2024
Q2 | $24.7K | Buy |
+4,224
| New | +$24.7K | ﹤0.01% | 3631 |
|
|
2024
Q1 | – | Sell |
-43
| Closed | -$251 | – | 6142 |
|
|
2023
Q4 | $251 | Buy |
+43
| New | +$251 | ﹤0.01% | 5632 |
|
|
2023
Q2 | – | Sell |
-4,147
| Closed | -$9K | – | 6329 |
|
|
2023
Q1 | $9K | Sell |
4,147
-2,108
| -34% | -$4.58K | ﹤0.01% | 4545 |
|
|
2022
Q4 | $10K | Buy |
6,255
+212
| +4% | +$339 | ﹤0.01% | 4081 |
|
|
2022
Q3 | $18K | Sell |
6,043
-2,984
| -33% | -$8.89K | ﹤0.01% | 4026 |
|
|
2022
Q2 | $28K | Buy |
9,027
+1,138
| +14% | +$3.53K | ﹤0.01% | 3456 |
|
|
2022
Q1 | $22K | Buy |
7,889
+4,119
| +109% | +$11.5K | ﹤0.01% | 3451 |
|
|
2021
Q4 | $17K | Buy |
+3,770
| New | +$17K | ﹤0.01% | 3867 |
|